🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Canagliflozin (JNJ-28431754) 300 mg

Found 39 matching trials

A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the bioequivalence of a fixed dose...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01463228

Treatments Being Tested

A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)B (canagliflozin/metformin IR FDC tablets / A (canagliflozin and metformin IR individual tablets)

A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers

PHASE1

The purpose of the study is to assess the effect of multiple oral doses of ...

Status

Completed

Location

Multiple Locations

Start Date

2010-09

Trial ID

NCT01195324

Treatments Being Tested

Canagliflozin/Warfarin Canagliflozin/Warfarin

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

PHASE4

The purpose of this study is to assess the effect of canagliflozin (JNJ-284...

Status

Completed

Location

Multiple Locations

Start Date

2014-02

Trial ID

NCT02025907

Treatments Being Tested

Canagliflozin, 100 mg Canagliflozin, 300 mg Placebo

The Effect of Food on the Administration of Canagliflozin in Healthy Adult Volunteers

PHASE1

The purpose of this study is to assess the effect of food on the absorption...

Status

Completed

Location

Multiple Locations

Start Date

2011-04

Trial ID

NCT01343290

Treatments Being Tested

Canagliflozin

A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the effect of dose on the pharmaco...

Status

Completed

Location

Multiple Locations

Start Date

2011-05

Trial ID

NCT01340677

Treatments Being Tested

Canagliflozin, 50 mg Canagliflozin, 300 mg Canagliflozin, 100 mg

A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)

PHASE1

The purpose of this study is to assess the effect of canagliflozin (JNJ-284...

Status

Completed

Location

Multiple Locations

Start Date

2008-06

Trial ID

NCT01787357

Treatments Being Tested

Canagliflozin (JNJ-28431754)Placebo Moxifloxacin

CANVAS - CANagliflozin cardioVascular Assessment Study

PHASE3

The study will assess canagliflozin (JNJ-28431754) in the treatment of pati...

Status

Completed

Location

Multiple Locations

Start Date

2009-12-09

Trial ID

NCT01032629

Treatments Being Tested

Placebo Canagliflozin (JNJ-28431754) 100 mg Canagliflozin (JNJ-28431754) 300 mg

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

PHASE1

The purpose of this study is to evaluate the safety, tolerability, pharmaco...

Status

Completed

Location

Multiple Locations

Start Date

2008-05

Trial ID

NCT01177163

Treatments Being Tested

Placebo JNJ 28431754 300 mg/placebo JNJ 28431754 100 mg/placebo

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the bioequivalence of fixed dose c...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01518712

Treatments Being Tested

A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)B (canagliflozin/metformin IR FDC tablets / A (canagliflozin and metformin IR individual tablets)

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

PHASE1

The purpose of this study is to evaluate the safety, tolerability, pharmaco...

Status

Completed

Location

Multiple Locations

Start Date

2007-06

Trial ID

NCT00963768

Treatments Being Tested

JNJ 28431754 Placebo

Previous Next